Nerfasin 20 recall in Canada: quality issue
In plain language
This recall involves Nerfasin 20, a veterinary drug, sold in Canada. It's being recalled because the affected lot may contain particles. Consult your healthcare provider before stopping use and follow the return steps in the official notice.
What to do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use.
- Contact the recalling firm if you have questions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Nerfasin 20
Lot: 19J038
Why this matters
Product quality issue (presence of particles)
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: 19J038
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Product quality issue (presence of particles)
What should consumers do?
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use. Contact the recalling firm if you have questions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Product quality issue (presence of particles)
When was this product recalled?
This product was recalled on November 30, 2021.
Is the Nerfasin 20 brand affected by this recall?
Yes, Nerfasin 20 products are affected by this recall. This recall involves Nerfasin 20, a veterinary drug, sold in Canada. It's being recalled because the affected lot may contain particles. Consult your healthcare provider before stopping use and follow the return steps in the official notice.